Antoinette Anazodo

Dr Antoinette Anazodo trained in Paediatric and Adolescent Oncology in the United Kingdom and completed her training with a clinical fellowship in the Kids Cancer Centre at Sydney Children’s Hospital. During her training and Fellowship, Antoinette completed a postgraduate diploma in Adolescent Oncology. She has developed a comprehensive understanding of the issues specific to Adolescent and Young Adult (AYA) patients, including best practice for individual cancer types. In October 2020 Antoinette was appointed Director of Adolescent and Young Adult Cancer at Sydney Children’s and Prince of Wales Hospital and has subsequently developed a comprehensive AYA cancer service across both the paediatric and adult cancer centre. She has been part of the AYA national leadership group working with national and state partners to develop specialist Youth Cancer Services across Australia providing vital treatment and support to young patients. Antoinette leads the Future Fertility research program on reproductive concerns of cancer patients and in addition to the medical and psychological studies, she has been instrumental in the development of Medicare item numbers for public funding for oncofertility care in Australia and leads international work on oncofertility models of care and a global competency framework. Dr Anazodo is the chair for the Australian AYA fertility preservation group and guidelines group. Antoinette is a member of the national COSA AYA Cancer Steering Group, Chair of the NSW and ACT AYA Steering Group, member of the CanTeen Steering Group and the CanTeen Research Group and a member of the Fertility Society of Australia Fertility Preservation Special Interest Group. Antoinette has received a number of awards, including a Champions Award from Prince of Wales Hospital, Pride of Australia award in 2015, her Churchill Fellowship in 2015, nomination for the Women of the Year in 2016 and 2017 for her work on reproductive concerns in cancer patients. She received the Cancer Institute NSW Premiers Award Rising Star and NSW Health People’s Choice Award, as well as the Primeirs Award in the Integrated health category.